SALARIUS PHARMA (SLRX)
$0.81
0.11 (13.45%)
SLRX Stock Earnings: Salarius Pharmaceuticals Beats EPS for Q2 2024
SLRX stock results show that Salarius Pharmaceuticals beat analyst estimates for earnings per share the second quarter of 2024.

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$0.86
Market Cap
1.61M
PE Ratio
-0.14
EPS
-5.6966
Volume (Avg. Vol.)
254,427
Day's Range
$0.81 - $0.94
52-Week Range
$0.81 - $7.20
Dividend & Yield
N/A (N/A)